Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can early speech therapy boost language in preterm babies?

NCT ID NCT04384328

Terminated Disease control Sponsor: Centre Hospitalier Sud Francilien Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an early speech therapy program for children born very prematurely or with severe growth restriction. The program involved 10 to 20 sessions with a trained speech therapist from 6 to 24 months of age. The goal was to see if it could reduce language and communication problems at age 2. The study was terminated early and included 76 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Early support programme in speech therapy (10-20 sessions from 6 to 24 months corrected age)
What this could lead to
If successful, this program could help reduce language and communication delays in children born very prematurely or with severe growth restriction.
What could go wrong
The study was terminated early and was small (76 participants), non-randomized, and open-label, so results may be limited and not generalizable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRAUTERINE GROWTH RESTRICTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fetal growth restriction Language Development Disorders Premature Birth language disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LANGUAGE DEVELOPMENT DISORDERS PRETERM BIRTH

Contacts and locations

Locations

  • Centre Hospitalier Louis Mourier

    Colombes, 92700, France

  • Centre Hospitalier Rives de Seine

    Neuilly-sur-Seine, 92200, France

  • Centre Hospitalier Sud Francilien

    Corbeil-Essonnes, 91100, France

  • Hôpital Antoine Béclère

    Clamart, 92141, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.